IL116456A0 - Oligonucleotide-dendrimer conjugates - Google Patents

Oligonucleotide-dendrimer conjugates

Info

Publication number
IL116456A0
IL116456A0 IL11645695A IL11645695A IL116456A0 IL 116456 A0 IL116456 A0 IL 116456A0 IL 11645695 A IL11645695 A IL 11645695A IL 11645695 A IL11645695 A IL 11645695A IL 116456 A0 IL116456 A0 IL 116456A0
Authority
IL
Israel
Prior art keywords
oligonucleotide
dendrimer conjugates
dendrimer
conjugates
Prior art date
Application number
IL11645695A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL116456A0 publication Critical patent/IL116456A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
IL11645695A 1994-12-21 1995-12-19 Oligonucleotide-dendrimer conjugates IL116456A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH385494 1994-12-21
CH4795 1995-01-09

Publications (1)

Publication Number Publication Date
IL116456A0 true IL116456A0 (en) 1996-03-31

Family

ID=25683356

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11645695A IL116456A0 (en) 1994-12-21 1995-12-19 Oligonucleotide-dendrimer conjugates

Country Status (9)

Country Link
EP (1) EP0790837A1 (fi)
JP (1) JPH10510822A (fi)
AU (1) AU4344696A (fi)
CA (1) CA2206915A1 (fi)
FI (1) FI972548A (fi)
HU (1) HUT77521A (fi)
IL (1) IL116456A0 (fi)
NO (1) NO972868L (fi)
WO (1) WO1996019240A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563255A (en) * 1994-05-31 1996-10-08 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
US5744460A (en) * 1996-03-07 1998-04-28 Novartis Corporation Combination for treatment of proliferative diseases
CA2291839A1 (en) * 1997-05-28 1998-12-03 Peter E. Nielsen Conjugated peptide nucleic acids having enhanced cellular uptake
GB9718129D0 (en) 1997-08-27 1997-10-29 Isis Innovation Branched structures
US6287765B1 (en) * 1998-05-20 2001-09-11 Molecular Machines, Inc. Methods for detecting and identifying single molecules
FR2906532B1 (fr) 2006-09-28 2008-12-12 Biomerieux Sa Nouvel oligonucleotide marque
FR2933410B1 (fr) 2008-07-04 2010-08-20 Biomerieux Sa Nouvelle sonde de detection
JOP20210186A1 (ar) 2019-01-10 2023-01-30 Janssen Biotech Inc مستضدات البروستاتا المستحدثة واستخداماتها
US12018289B2 (en) 2019-11-18 2024-06-25 Janssen Biotech, Inc. Vaccines based on mutant CALR and JAK2 and their uses
CN112898580B (zh) * 2019-12-03 2022-11-08 安序源生物科技(深圳)有限公司 测序试剂
CN112898575B (zh) * 2019-12-03 2022-10-21 深圳清华大学研究院 树杈状大分子修饰的核苷酸的制备方法
EP4175721A1 (en) 2020-07-06 2023-05-10 Janssen Biotech, Inc. Prostate neoantigens and their uses
US20230029453A1 (en) 2020-07-06 2023-02-02 Janssen Biotech, Inc. Prostate Neoantigens And Their Uses
EP4176087A1 (en) 2020-07-06 2023-05-10 Janssen Biotech, Inc. A method for determining responsiveness to prostate cancer treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE89743T1 (de) * 1986-08-18 1993-06-15 Dow Chemical Co Conjugate dichter sterne.
IL107715A0 (en) * 1992-11-25 1994-02-27 Baxter Int Water soluble non-immunogenic polyamide cross-linking agents
DE69433519T2 (de) * 1993-07-14 2004-11-11 The Regents Of The University Of California, Oakland Sich selbst zusammensetzendes polynukleotid-abgabesystem, das dendrimer-polykationen enthält
ZA951877B (en) * 1994-03-07 1996-09-09 Dow Chemical Co Bioactive and/or targeted dendrimer conjugates
IT1270994B (it) * 1994-03-18 1997-05-26 Bracco Spa Macromolecole ramificate a struttura poliossialchilica e loro usi

Also Published As

Publication number Publication date
FI972548A0 (fi) 1997-06-16
FI972548A (fi) 1997-06-23
WO1996019240A1 (en) 1996-06-27
HUT77521A (hu) 1998-05-28
CA2206915A1 (en) 1996-06-27
EP0790837A1 (en) 1997-08-27
NO972868L (no) 1997-08-19
AU4344696A (en) 1996-07-10
JPH10510822A (ja) 1998-10-20
NO972868D0 (no) 1997-06-20

Similar Documents

Publication Publication Date Title
TJ328B (en) Interferron conjugates
DE69530493D1 (en) Ablationsgerät
GB9520261D0 (en) Bisresorcinyltriazines
EP0765166A4 (en) RADIOACTIVELY MARKED ANNEXIN GALACTOSE CONJUGATES
GB2296715B (en) Bisallyloxyimides
IL116456A0 (en) Oligonucleotide-dendrimer conjugates
GB9414164D0 (en) Drillclamp
ZA9510671B (en) Thienopyridone
GB9421417D0 (en) Golf-mate
AU122938S (en) Breadbox
ZA9510827B (en) Oligonucleotide-dendrimer conjugates
HU9500002D0 (en) Horn-clamp
CA73798S (en) Air-purifier
KR970007046Y1 (en) Rolling-roll
GB9422971D0 (en) Two part keepnet
ZA951608B (en) Inclusion complex
GB9400761D0 (en) Carbohydrate conjugates
HU9400316V0 (en) Fruit-stoner
AU121214S (en) Homeware
PL55753Y1 (en) Doll-baby
HU9400948D0 (en) Thermopack
HU9400846D0 (en) Roof-advertisment
PL56437Y1 (en) Sepulchral stoup
HU706U (en) Counter-in-the-slot-machine
SI0772610T1 (en) Dihydrobenzofuranes